.png){kind=icon}
.png){kind=icon}
Return
Ceftriaxone-induced liver injury: Incidence, phenotypic characterization and predictive factors
.png){kind=icon}
OA
AI
M
M
H
M
A
L
DOI：10.1002/bcp.70657.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Ceftriaxone is a widely used third-generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug-induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed to evaluate the incidence, characterize clinical phenotypes, and identify risk factors for ceftriaxone-induced liver injury.
Keywords:
ceftriaxone
cholestatic injury
drug-induced liver injury
hepatotoxicity
incidence
predictors
Journal
IF:
3
Papers:
8.5K
Citations:
1.8W
Organization
Cited Papers